|
Abstract
It's estimated that in the forthcoming couple of years, the growth rate of the sales income of the medical industry will remain at 15-17%. In the long term, thanks to the highest growth speed, China's medical market will become the world's 7th largest market in 2010 and the 2nd in 2020, only behind America.
Compared with developed countries like America, China's current medical enterprises have small scales, unapparent product differentiation and low industrial concentricity. They are facing low-level but furious competition.
At present, there are over 1000 healthcare product enterprises in China, generating the annual sales value of RMB 50 billion and growing by 15-20% yearly. Due to the continuously issued regulation policies as well as high barriers of direct marketing policies, the concentration degree of the healthcare industry will be remarkably improved. By virtue of its competitive advantages, Chinese traditional healthcare products will take a critical position in the industry in the future.
Sales Revenue and Growth Rate of China's Medical Industry
Ranking of China's Industrial and Commercial Medical Enterprises, 2005 (RMB Billion)
Table of Content
1 Analysis on the development of China's medical industry
1.1. Medical industry maintains rapid growth during 2006-2007
1.2. Chinese medical industry takes the lead in growth rate throughout the world
1.3. Increasingly ascended ranking in the global medical market
1.4. China's medical market demand remains vigorous
2. Analysis on the development of China's medical enterprises
2.1 Enterprises with competitive advantages emerge
2.2 Excessively redundant construction in the medical industry
2.3 Production capacity utilization rate of the medical industry tends to be exasperated
2.4 Low concentricity of China's medical enterprises
2.5 Competitive means of medical sub-industries are different
2.6 Evolvement in product structure may bring 3 main markets
3 Analysis on China's healthcare product industry
3.1Overview
3.2 Favorable factors
3.3 Vigorous demand
3.4 Expectable rapid growth
3.5 Superior wins while inferior loses
3.6 List of direct marketing enterprises
3.7 Advantages of traditional Chinese healthcare products
4 Analysis on major listed companies
4.1 Shandong Dong-E E-Jiao Co., Ltd.
4.2 Shanghai Pharmaceutical (Group) Co., Ltd.
4.3 Huadong Medicine Co., Ltd.
4.4 Hengrui Medicine Co., Ltd.
5 Appendixes
5.1. China's health system reform will be important but hard
5.2. Concept of universal medical insurance
5.3. Trisected medical industry of China
5.4. Classified drug management promotes the growth of OTC market
5.5. Slowed growth rate of the world's medical industry
5.6. America, the world's foremost medical market
5.7. New medicine in the markets of China and America
Selected Charts
Sales income and growth rate of China's medical industry, 1998-2007
CAGR in sales income of the medical industry by country, 2004-2009
Proportion of per capital healthcare expense to the total consumption expenditure in urban areas
Proportion of per capital healthcare expense to the total consumption expenditure in rural areas
Rural and urban populations of China, 1995-2005
Morbidity of residents in two weeks
Doctor visiting rate of residents in two weeks
Composition of China's total sanitation expenditure, 1990-2004
Number of urban people covered by insurance, 1999-2006
Statistics and forecast of amount of China's senior citizens
Idle capacity ratio of China's medical industry
Market share of medical industry and medical commerce, 2002-2005
Proportion of net profits of listed medical enterprises, 2001-2005
Healthcare products by approval number
Per capita expenditure on healthcare products by region
Statistics of people's health conditions
Income of China's healthcare product industry, 2002-2006
Registered capital of China's healthcare product companies
Statistics of sales income by marketing pattern
Advantages of traditional Chinese healthcare products
China's health system reform
Content of functional healthcare food prescribed by the Ministry of Public Health
Industrial structure of the medical industry
Drug classification of China
Sales income from chemical preparations of China, 2000-2005
Sales income from chemical raw material medicine of China, 2000-2005
Sales income from traditional Chinese medicine of China, 2000-2005
Profit of China's chemical preparations, 2000-2005
Profit of China's chemical raw material medicine, 2000-2005
Profit of China's traditional Chinese medicine, 2000-2005
Statistics and forecast of sales income from OTC drugs, 2001-2007
Distribution of drug sales income in China, 2006
Statistics and forecast of China's medical market scale, 1998-2007
Global medical market distribution, 2005
Estimated global medical market distribution, 2010
Comparison of Chinese, American and Indian medical industries
Quantity of America's new drugs, 1995-2004
Differences between Chinese and global best-selling drugs, 2005
Statistics and forecast of ranking of global medical market
Implementation of new rural cooperative medical system in China
Ranking of industrial and commercial medical enterprises, 2005 (RMB Billion)
Competition characteristics of medical sub-industries
Three main markets of the medical industry
Difference between healthcare products and drugs
Development process of China's healthcare product industry
Classification of healthcare products by purpose
List of approved direct marketing enterprises in China
Amount of China's new drugs, 2003-2006
Quantity comparison of Chinese and American medical enterprises
Statistics of drug declaration
|
Published Time |
Pages |
Publisher |
Price |
|
June/2007 |
30 |
ResearchInChina |
$449(PDF) |
|
$449(Hard Copy) |
|
您现在的位置： 
